Media Centre
Press releases
AM-Pharma Announces Enrollment and Financing of COVID-19 Cohort in Phase III REVIVAL Trial
- First patients with COVID-19 enrolled in the REVIVAL Phase…
AM-Pharma Announces Enrollment of the First Patient in REVIVAL Phase III Pivotal Trial in Patients with Sepsis-Associated Acute Kidney Injury
- Trial to confirm potential of AM-Pharma’s recombinant alkaline…
AM-Pharma Announces the Appointment of Rita Jain M.D. to its Supervisory Board
Utrecht, The Netherlands, 1 July 2020 – AM-Pharma B.V., an…
AM-Pharma Adds Regulatory, Business Development and Legal Expertise to Leadership Team
Utrecht, The Netherlands, June 29, 2020 – AM-Pharma B.V., an…
Publications
Alkaline phosphatase in sepsis-induced AKI
View publication
Alkaline phosphatase for treatment of sepsisinduced acute kidney injury: a prospective randomized double-blind placebo-controlled trial
View publication
Exogenous Alkaline Phosphatase for the Treatment of Patients with Moderate to Severe Ulcerative Colitis
View publication
Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients
View publication